The gene expression signature of metabolic dysfunction- associated steatotic liver disease from a multiomics perspective
- PMID: 38311818
- PMCID: PMC11016489
- DOI: 10.3350/cmh.2024.0082
The gene expression signature of metabolic dysfunction- associated steatotic liver disease from a multiomics perspective
Keywords: Gene expression; HCC; MASH; MASLD; OMICS.
Conflict of interest statement
 
The authors have no conflicts to disclose.
Comment on
- 
  
  Identification of signature gene set as highly accurate determination of metabolic dysfunction-associated steatotic liver disease progression.Clin Mol Hepatol. 2024 Apr;30(2):247-262. doi: 10.3350/cmh.2023.0449. Epub 2024 Jan 26. Clin Mol Hepatol. 2024. PMID: 38281815 Free PMC article.
References
- 
    - Sookoian S, Rosselli MS, Gemma C, Burgueño AL, Fernández Gianotti T, et al. Epigenetic regulation of insulin resistance in nonalcoholic fatty liver disease: impact of liver methylation of the peroxisome proliferator-activated receptor γ coactivator 1α promoter. Hepatology. 2010;52:1992–2000. - PubMed
 
- 
    - Pirola CJ, Sookoian S. Metabolic dysfunction-associated fatty liver disease: advances in genetic and epigenetic implications. Curr Opin Lipidol. 2022;33:95–102. - PubMed
 
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
- Full Text Sources
- Medical
 
        